Followers | 29 |
Posts | 6477 |
Boards Moderated | 0 |
Alias Born | 05/17/2011 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, May 31, 2019 8:31:48 AM
Recent RGNX News
- REGENXBIO Announces Expansion of AFFINITY DUCHENNE® Trial to Include a New Cohort of Younger Patients • PR Newswire (US) • 06/24/2024 11:05:00 AM
- REGENXBIO Announces Successful Pre-BLA Meeting with FDA to Support Accelerated Approval Pathway for RGX-121 for the Treatment of MPS II • PR Newswire (US) • 06/18/2024 11:05:00 AM
- REGENXBIO Announces Leadership Transition • PR Newswire (US) • 06/12/2024 11:05:00 AM
- REGENXBIO to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • PR Newswire (US) • 06/05/2024 11:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:43:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:42:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:41:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:41:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:35:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 09:06:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2024 08:22:51 PM
- REGENXBIO to Participate in Upcoming Investor Conferences • PR Newswire (US) • 05/10/2024 11:05:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:16:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:10:26 PM
- REGENXBIO Reports First Quarter 2024 Financial Results and Recent Operational Highlights • PR Newswire (US) • 05/08/2024 08:05:00 PM
- REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2024 Financial Results and Recent Operational Highlights • PR Newswire (US) • 05/01/2024 11:05:00 AM
- REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit • PR Newswire (US) • 04/24/2024 11:05:00 AM
- REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD • PR Newswire (US) • 03/28/2024 11:05:00 AM
- REGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD and Other Dystrophy Days • PR Newswire (US) • 03/27/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 12:00:31 PM
- REGENXBIO to Participate in Upcoming Investor Conferences • PR Newswire (US) • 03/11/2024 11:05:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/08/2024 11:09:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:05:43 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 03/07/2024 11:03:26 AM
- REGENXBIO Announces Pricing of Upsized Public Offering of Common Stock and Pre-funded Warrants • PR Newswire (US) • 03/07/2024 04:20:00 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM